<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03891316</url>
  </required_header>
  <id_info>
    <org_study_id>PV5820</org_study_id>
    <nct_id>NCT03891316</nct_id>
  </id_info>
  <brief_title>Sevoflurane Human Biomonitoring in Operating Room Personnel</brief_title>
  <official_title>Human Biomonitoring of Operating Room Personnel With Occupational Exposure to the Volatile Anaesthetic Sevoflurane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sevoflurane is a widely used volatile agent for induction and maintenance of anaesthesia. The
      administration of sevoflurane involves the risk of occupational exposure. Possible negative
      implications of chronic occupational exposure to sevoflurane are not completely refuted. In
      Germany no maximum workplace concentration for sevoflurane is defined. This study aims to
      find out if working conditions of physicians and different anaesthesia techniques effect the
      extent of occupational exposure to sevoflurane.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective observational trial 5 cohorts of 4 participants each are investigated.
      The cohorts consist of physicians working at different places in the operating theatre with
      different occupational exposure to sevoflurane and one cohort not working in the operating
      theatre at all. In order to determine the extent of occupational exposure to sevoflurane a
      human biomonitoring is conducted. Urinary Sevoflurane and its metabolite
      hexafluoroisopropanol (HFIP) are measured after 3 consecutive working days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 11, 2019</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary HFIP concentration (µg/l)</measure>
    <time_frame>After 3 consecutive days of work</time_frame>
    <description>After 3 consecutive days of work a urine sample is collected and urinary HFIP is measured by gas chromatography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary sevoflurane concentration (µg/l)</measure>
    <time_frame>After 3 consecutive days of work</time_frame>
    <description>After 3 consecutive days of work a urine sample is collected and urinary sevoflurane is measured by gas chromatography</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Occupational Exposure</condition>
  <arm_group>
    <arm_group_label>Anaesthesiologists balanced</arm_group_label>
    <description>Anaesthesiologists performing balanced anaesthesia with sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anaesthesiologists TIVA</arm_group_label>
    <description>Anaesthesiologists performing only total intravenous anaesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgeons</arm_group_label>
    <description>Surgeons working in the operating room while anaesthesia of the patients is randomly maintained with sevoflurane or propofol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anaesthesiologists PACU</arm_group_label>
    <description>Anaestesiologists working in the postoperative care unit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physicians not exposed</arm_group_label>
    <description>Physicans working outside of the operating theatre.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>HFIP and Sevoflurane are measured after 3 consecutive days of work.</intervention_name>
    <description>Concentration of Hexafluorisopropanol and Sevoflurane are measured in urine by gas chromatography</description>
    <arm_group_label>Anaesthesiologists PACU</arm_group_label>
    <arm_group_label>Anaesthesiologists TIVA</arm_group_label>
    <arm_group_label>Anaesthesiologists balanced</arm_group_label>
    <arm_group_label>Physicians not exposed</arm_group_label>
    <arm_group_label>Surgeons</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urinary Samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Physicans with or without occupational exposure to sevoflurane.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Occupational exposure to sevoflurane while conducting sevoflurane anaesthesia/being
             present during sevoflurane anaesthesia

          -  Possible occupational exposure to sevoflurane while working in the operating
             room/perioperative anaesthesia care unit

          -  No occupational exposure to sevoflurane (working outside the operating theatre)

        Exclusion Criteria:

          -  Presence during a mask induction with sevoflurane
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katharina Roeher, Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katharina Roeher, Dr. med</last_name>
    <phone>+4940741052415</phone>
    <email>k.roeher@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joana Neppert, Dr. med</last_name>
    <email>j.wilgusch@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katharina Roeher, Dr. med.</last_name>
      <phone>+4940741052415</phone>
      <email>k.roeher@uke.de</email>
    </contact>
    <contact_backup>
      <last_name>Joana Neppert, Dr. med.</last_name>
      <phone>+4940741052415</phone>
      <email>j.wilgusch@uke.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>March 10, 2019</study_first_submitted>
  <study_first_submitted_qc>March 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2019</study_first_posted>
  <last_update_submitted>October 12, 2019</last_update_submitted>
  <last_update_submitted_qc>October 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

